Expanding role of circulating adhesion molecules in assessing prognosis and treatment response in human immunodeficiency virus infection

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 6, 2004, Pages 996-1001

  Sipsas, Nikolaos V ^a   Sfikakis, Petros P ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; PADGEM PROTEIN; SELECTIN; VASCULAR CELL ADHESION MOLECULE 1; ZIDOVUDINE;

HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SHORT SURVEY; TREATMENT OUTCOME;

CELL ADHESION MOLECULES; GENE EXPRESSION REGULATION; HIV; HIV INFECTIONS; HUMANS; LEUKOCYTES; PROGNOSIS;

EID: 9144251760     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.6.996-1001.2004     Document Type: Short Survey

References (92)

1. Aceti, A., A. Benedetto, and A. Sebastiani. 1994. Circulating intercellular adhesion molecule-1 in human immunodeficiency virus infection. J. Infect. Dis. 169:1176.
2. Aukrust, P., F. Muller, E. Lien, I. Nordoy, N. B. Liabakk, D. Kvale, T. Espevik, and S. S. Froland. 1999. Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure. J. Infect. Dis. 179:74-82.
3. Becker, K., M. Heins, T. Sudhoff, H. Renauer, and D. Haussinger. 1997. Specific pattern of circulating endothelial adhesion molecules in HIV-associated Kaposi's sarcoma. Int. Arch. Allergy Immunol. 113:512-515.
4. Bevilacqua, M. P., and R. M. Nelson. 1993. Selectins. J. Clin. Investig. 91: 379-387.
5. Bisset, L. R., R. W. Cone, W. Huber, M. Battegay, P. L. Vernazza, R. Weber, P. J. Grob, M. Opravil, et al. 1998. Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. AIDS 12:2115-2123.
6. Blann, A. 2002. Raised soluble P selectin and the risk of thrombosis in HIV-1 infection. Thromb. Haemost. 88:1078.
7. Blann, A. D., and G. Y. H. Lip. 1997, Hypothesis: is soluble P-selectin a new marker for platelet activation? Atherosclerosis 128:135-138.
8. Blann, A. D., M. Seigneur, J. Constans, J. L. Pellegrin, and C. Conri. 1997. Soluble P-selectin, thrombocytopenia and von Willebrand factor in HIV infected patients. Thromb. Haemost. 77:1221-1222.
9. Bohnet, S., J. Braun, and K. Dalhoff. 1994. Intercellular adhesion molecule-1 (ICAM-1) is upregulated on alveolar macrophages from AIDS patients. Eur. Respir. J. 7:229-234.
10. Butini, L., A. R. De Fougerolles, M. Vaccarezza, C. Graziosi, D. I. Cohen, M. Montroni, T. A. Springer, G. Pantaleo, and A. S. Fauci. 1994. Intercellular adhesion molecules ICAM-1, ICAM-2, and ICAM-3 function as counter-receptors for lymphocyte function-associated molecule 1 in human immunodeficiency virus-mediated syncytia formation. Eur. J. Immunol. 24:2191-2195.
11. Chehimi, J., S. E. Starr, I. Frank, A. D'Andrea, X. Ma, R. R. MacGregor, J. Sennelier, and G. Trinchieri. 1994. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179:1361-1366.
12. Chirmule, N., T. W. McCloskey, R. Hu, V. S. Kalyanaraman, and S. Pahwa. 1995. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71). J. Immunol. 155: 917-924.
13. Clark, E. A., and J. A. Ledbetter. 1994. How B and T cells talk to each other. Nature 367:425-428.
14. Cohen, O. J., A. Kinter, and A. Fauci. 1997. Host factors in the pathogenesis of HIV disease. Immunol. Rev. 159:31-48.
15. + T lymphocytes. Proc. Natl. Acad. Sci. USA 88:6403-6407.
16. de Gaetano Donati, K., R. Rabagliati, M. Tumbarello, E. Tacconelli, C. Amore, R. Cauda, and L. Lacoviello. 2003. Increased soluble markers of endothelial dysfunction in HIV-positive patients under highly active antiretroviral therapy. AIDS 17:765-768.
17. de Larranaga, G. F., A. R. Bocassi, L. M. Puga, B. S. Alonzo, and J. A. Benetucci. 2003. Endothelial markers and HIV infection in the era of highly active antiretroviral treatment. Thromb. Res. 110:93-98.
18. De Milito, A., K. Titanji, and M. Zazzi. 2003. Surrogate markers as a guide to evaluate response to antiretroviral therapy. Curr. Med. Chem. 10:349-365.
19. De Paoli, P., C. Caffau, M. D'Andrea, M. Tavio, U. Tirelli, and G. Santini. 1994. Serum levels of intercellular adhesion molecule 1 in patients with HIV-related Kaposi's sarcoma. J. Acquir. Immune Defic. Syndr. 7:695-699.
20. Dhawan, S., R. K. Puri, A. Kumar, H. Duplan, J. M. Masson, and B. B. Aggarwal. 1997. Human immunodeficiency virus-1 Tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells. Blood 90:1535-1544.
21. Diez-Ruiz, A., G. Kaiser, H. Jager, J. Birkmann, G. P. Tilz, H. Wachter, and D. Fuchs. 1993. Increased levels of serum intercellular adhesion molecule 1 in HIV infection are related to immune activation. Int. Arch. Allergy Immunol. 102:56-60.
22. Di Marzio, P., R. Mariani, R. Lui, E. K. Thomas, and N. R. Landau. 2000. Soluble CD40 ligand induces beta-chemokine production by macrophages and resistance to HIV-1 entry. Cytokine 12:1489-1495.
23. Fahey, J. L., J. M. G. Taylor, B. Manna, P. Nishanian, N. Aziz, J. V. Giorgi, and R. Detels. 1998. Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements. AIDS 12:1581-1590.
24. Fahey, J. L. 1998. Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection. Clin. Diagn. Lab. Immunol. 5:597-603.
25. Gaddi, E., S. Laucella, J. Balbaryski, C. Cantisano, G. Barboni, M. Candi, and V. Giraudi. 2000. Prognostic value of soluble intercellular adhesion molecule-1 (s-ICAM-1) in HIV-infected children. Scand. J. Immunol. 52: 628-633.
26. Galea, P., C. Vermot-Desroches, C. Le Contel, J. Wijdenes, and J. C. Chermann. 1997. Circulating cell adhesion molecules in HIV-1-infected patients as indicator markers for AIDS progression. Res. Immunol. 148:109-117.
27. Gamble, J. R., M. P. Skinner, M. C. Berndt, and M. A. Vadas. 1990. Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP140. Science 249:414-417.
28. Gattegno, L., M. Bentata-Peyssare, S. Gronowski, K. Chaouche, and F. Ferriere. 1995. Elevated concentrations of circulating intercellular adhesion molecule 1 (ICAM-1) and of vascular cell adhesion molecule 1 (VCAM-1) in HIV-1 infection. Cell. Adhes. Commun. 3:179-185.
29. Gearing, A. J., and W. Newman. 1993. Circulating adhesion molecules in disease. Immunol. Today 14:506-512.
30. Grewal, I. S., and R. A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111-135.
31. Hashimoto, M., M. Shingu, I. Ezaki, M. Nobunaga, M. Minamihara, K. Kato, and H. Sumioki. 1994. Production of soluble ICAM-1 from human endothelial cells induced by IL-1β and TNF-α. Inflammation 18:163-173.
32. Hayes, P. J., Y. M. Miao, F. M. Gotch, and B. G. Gazzard. 1999. Alterations in blood leukocyte adhesion molecule profiles in HIV-1 infection. Clin. Exp. Immunol. 117:331-334.
33. Heidenreich, F., G. Arendt, S. Jander, H. Jablonowski, and G. Stoll. 1994. Serum and cerebrospinal fluid levels of soluble intercellular adhesion molecule 1 (sICAM-1) in patients with HIV-1 associated neurological diseases. J. Neuroimmunol. 52:117-126.
34. Hioe, C. E., L. Bastiani, J. E. Hildreth, and S. Zolla-Pazner. 1998. Role of cellular adhesion molecules in HIV type 1 infection and their impact on virus neutralization. AIDS Res. Hum. Retrovir. 14(Suppl. 3):S247-S254.
35. Hofman, F. M., A. D. Wright, M. M. Dohadwala, F. Wong-Staal, and S. M. Walker. 1993. Exogenous tat protein activates human endothelial cells. Blood 82:2774-2780.
36. Jassoy, C., M. Heinkelein, H. Klinker, and B. D. Walker. 1994. HIV type 1-specific cytotoxic T lymphocytes stimulate HLA class I and intercellular adhesion molecule type 1 expression and increase β2-microglobulin levels in vitro. AIDS Res. Hum. Retrovir. 10:1685-1693.
37. Karmann, K., C. C. Hughes, J. Schechner, W. C. Fanslow, and J. S. Pober. 1995. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. USA 92:4342-4346.
38. Kornbluth, R. S. 2000. The emerging role of CD40 ligand in HIV infection. J. Leukoc. Biol. 68:373-382.
39. Kornbluth, R. S. 2002. An expanding role for CD40L and other tumor necrosis factor superfamily ligands in HIV infection. J. Hematother. Stem Cell Res. 11:787-801.
40. Kornbluth, R. S., K. Kee, and D. D. Richman. 1998. CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines. Proc. Natl. Acad. Sci. USA 95:5205-5210.
41. Lane, P., T. Brocker, S. Hubele, E. Padovan, A. Lanzavecchia, and F. McConnell. 1993. Soluble CD40 ligand can replace the normal T cell derived CD40 ligand signal to B cells in T cell-dependent activation. J. Exp. Med. 177:1209-1213.
42. Lenschow, D. J., T. I. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233-258.
43. Ley, K., and T. F. Tedder. 1995. Leukocyte interactions with vascular endothelium. New insights into selectin-mediated attachment and rolling. J. Immunol. 155:525-528.
44. Lo, S. K., S. Lee, R. A. Ramos, R. Lobb, M. Rosa, G. Chi-Rosso, and S. D. Wright. 1991. Endothelial-leukocyte adhesion molecule 1 stimulates the adhesive activity of leukocyte integrin CR3 (CD11b/CD18, Mac-1, αmβ2) on human neutrophils. J. Exp. Med. 173:1493-1500.
45. Mastroianni, C. M., M. Lichtner, F. Mengoni, C. D'Agostino, G. d'Ettorre, G. Forcina, P. Santopadre, A. P. Massetti, and V. Vullo. 2000. Changes in circulating levels of soluble cell adhesion molecules following highly active antiretroviral treatment of HIV-1-infected patients. Clin. Immunol. 95:212-217.
46. + lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med. 126:946-954.
47. Moore, D. A. J., D. Henderson, and B. G. Gazzard. 1998. Neutrophil adhesion molecules in HIV disease. Clin. Exp. Immunol. 114:73-77.
48. Moore, D. A. J., D. Henderson, F. Gotch, and B. Gazzard. 1998. Reversal of abnormalities of neutrophil adhesion molecule expression in HIV infection following protease inhibitor therapy. AIDS 12:2083-2084.
49. Moses, A. V., S. E. Williams, J. G. Strussenberg, M. L. Heneveld, R. A. Ruhl, G. C. Bakke, and J. A. Nelson. 1997. HIV-1 induction of CD40 on endothelial cells promotes the outgrowth of AIDS-associated B-cell lymphomas. Nat. Med. 3:1242-1243.
50. Most, J., R. Zangerle, M. Herold, D. Fuchs, H. Wachter, P. Fritsch, and M. P. Dierich. 1993. Elevated concentrations of circulating intercellular adhesion molecule 1 (ICAM-1) in HIV-1 infection. J. Acquir. Immune Defic. Syndr. 6:221-226.
51. Newman, W., L. D. Beall, C. W. Carson, G. G. Hunder, N. Graben, Z. I. Randhawa, T. V. Gopal, J. Wiener-Kronish, and M. A. Matthay. 1993. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J. Immunol. 150: 644-654.
52. Nordoy, I., P. Aukrust, F. Muller, and S. S. Froland. 1996. Abnormal levels of circulating adhesion molecules in HIV-1 infection with characteristic alterations in opportunistic infections. Clin. Immunol. Immunopathol. 81: 16-21.
53. Nottet, H. S., Y. Persidsky, V. G. Sasseville, A. N. Nukuna, P. Bock, O. H. Zhai, L. R. Sharer, R. D. McComb, S. Swindells, C. Soderland, and H. E. Gendelman. 1996. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J. Immunol. 156:1284-1295.
54. Obregon, E., C. Borner, J. Navarro, M. D. Gurbindo, E. Fernandez-Cruz, and M. A. Munoz-Fernandez. 1996. Elevated levels of circulating intercellular adhesion molecule 1 and tumor necrosis factor alpha in the serum of children vertically infected with HIV-1. Pediatr. AIDS HIV Infect. 7:413-417.
55. Osborn, L., C. Hession, R. Tizard, C. Vassallo, S. Luhowskyj, G. Chi-Rosso, and R. Lobb. 1989. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59:1203-1211.
56. Osmond, D. H., S. Shiboski, P. Bacchetti, E. E. Winger, and A. R. Moss. 1991. Immune activation markers and AIDS prognosis. AIDS 5:505-511.
57. Palella, F. J., Jr., K. M. Delaney, A. C. Moorman, M. O. Loveless, J. Fuhrer, G. A. Satten, D. J. Aschman, and S. D. Holmberg. 1998. Declining morbidity and mortality among patients with advanced HIV infection. N. Engl. J. Med. 338:853-860.
58. Pantaleo, G., C. Graziosi, and A. Fauci. 1993. The immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med. 328:327-339.
59. Park, S. W., W. Royal III, R. D. Semba, G. W. Wiegand, and D. E. Griffin. 1998. Expression of adhesion molecules and CD28 on T lymphocytes during human immunodeficiency virus infection. Clin. Diagn. Lab. Immunol. 5: 583-587.
60. Pigott, R., and C. Power. 1993. The adhesion molecule facts book. Academic Press, San Diego, Calif.
61. Pigott, R., L. P. Dilton, I. H. Heminway, and A. J. H. Gearing. 1992. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem. Biophys. Res. Commun. 187:584-589.
62. Plaeger, S., H. Z. Bass, P. Nishanian, J. Thomas, N. Aziz, R. Detels, J. King, W. Cumberland, M. Kemeny, and J. L. Fahey. 1999. The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes. Clin. Immunol. 90:238-246.
63. Plaeger-Marshall, S., P. Hultin, J. Bertolli, S. O'Rourke, R. Kobayashi, A. L. Kobayashi, J. V. Giorgi, Y. Bryson, and E. R. Stiehm. 1993. Activation and differentiation antigens on T cells of healthy, at-risk, and HIV-infected children. J. Acquir. Immune Defic. Syndr. 6:984-993.
64. Puppo, F., S. Brenci, M. Scudeletti, L. Lanza, O. Bosco, and F. Indiveri. 1993. Elevated serum levels of circulating intercellular adhesion molecule-1 in HIV infection. AIDS 7:593-594.
65. Reddy, M. M., and M. H. Grieco. 1993. Elevated levels of soluble CD54 (ICAM-1) in human immunodeficiency virus infection. Clin. Lab. Anal. 7: 269-272.
66. Regezi, J. A., L. A. Macphail, D. W. Richards, and J. S. Greenspan. 1993. A study of macrophages, macrophage-related cells, and endothelial adhesion molecules in recurrent aphthous ulcers in HIV-positive patients. J. Dent. Res. 72:1549-1553.
67. Ren, Z., Q. Yao, and C. Chen. 2002. HIV-1 envelope glycoprotein 120 increases intercellular adhesion molecule-1 expression by human endothelial cells. Lab. Investig. 82:245-255.
68. Rieckmann, P., K. Nunke, M. Burchhardt, M. Albrecht, J. Wiltfang, M. Ulrich, and K. Felgenhauer. 1993, Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: an indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier. J. Neuroimmunol. 47:133-140.
69. Rothlein, R., E. A. Mainolfi, M. Czajkowski, and S. D. Marlin. 1991. A form of circulating ICAM-1 in human serum. J. Immunol. 147:3788-3793.
70. Rothlein, R., M. L. Dustin, S. D. Marlin, and T. A. Springer. 1986: A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J. Immunol. 137:1270-1274.
71. Sasseville, V. G., W. A. Newman, A. A. Lackner, M. O. Smith, N. C. Lausen, D. Beall, and D. J. Rangler. 1992. Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simian immunodeficiency virus. Am. J. Pathol. 141:1021-1030.
72. Schleiffenbaum, B., O. Spertini, and T. F. Tedder. 1992. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J. Cell Biol. 119:229-238.
73. Seigneur, M., J. Constans, A. Blann, M. Renard, J. L. Pellegrin, J. Amiral, M. Boisseau, and C. Conri. 1997. Soluble adhesion molecules and endothelial cell damage in HIV infected patients. Thromb. Haemost. 77:646-649.
74. Sfikakis, P. P., and G. C. Tsokos. 1995. Lymphocyte adhesion molecules in autoimmune rheumatic diseases: basic issues and clinical expectations. Clin. Exp. Rheumatol. 13:763-777.
75. Sfikakis, P. P., V. Tzavara, N. Sipsas, O. Kosmopoulou, and T. Kordossis. 1995. Levels of the circulating cell adhesion molecule E-selectin and disease progression in HIV infection. Infection 23:207-211.
76. Shimizu, Y., W. Newman, Y. Tanaka, and S. Shaw. 1992. Lymphocyte interaction with endothelial cells. Immunol. Today 13:106-113.
77. Sipsas, N., P. P. Sfikakis, P. Sfikakis, H. Choremi, and T. Kordossis. 1994. Serum concentrations of soluble intercellular adhesion molecule-1 and progress towards disease in patients infected with HIV. J. Infect. 29:271-282.
78. Sipsas, N. V., P. P. Sfikakis, G. Touloumi, N. Pantazis, H. Choremi, and T. Kordossis. 2003. Elevated serum levels of soluble immune activation markers are associated with increased risk for death in HAART-naïve HIV-1 infected patients. AIDS Patient Care STDs 17:147-153.
79. + T-cell counts. Clin. Diagn. Lab. Immunol. 9:558-561.
80. Sousa, A. E., A. F. Chaves, M. Doroana, F. Antunes, and R. M. Victorino. 1999. Early reduction of the over-expression of CD40L, OX40, and Fas on T cells in HIV-1 infection during triple anti-retroviral therapy: possible implications for lymphocyte traffic and functional recovery. Clin. Exp. Immunol. 116:307-315.
81. Spertini, O., B. Schleiffenbaum, C. White-Owen, P. Ruiz, Jr., and T. F. Tedder. 1992. ELISA for quantitation of L-selectin shed from leukocytes in vivo. J. Immunol. Methods 156:115-123.
82. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346: 425-433.
83. Swingler, S., B. Brichacek, J. M. Jacque, C. Ulich, J. Zhou, and M. Stevenson. 2003. HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature 424:213-219.
84. Tzavara, V., P. G. Vlachoyiannopoulos, T. Kordossis, D. Galaris, A. Travlou, U. Dafni, and H. M. Moutsopoulos. 1997. Evidence for non-adaptive immune response in HIV infection. Eur. J. Clin. Investig. 27:846-849.
85. van Seventer, G. A., Y. Shimizu, K. J. Horgan, and S. Shaw. 1990. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 144:4579-4582.
86. Wang, J., S. Marschner, and T. H. Finkel. 2004. CXCR4 engagement is required for HIV-1-induced L-selectin shedding. Blood 103:1218-1221.
87. Weeks, B. S. 1998. The role of HIV-1 activated leukocyte adhesion mechanisms and matrix metalloproteinase secretion in AIDS pathogenesis. Int. J. Mol. Med. 1:361-366.
88. Wittmann, M., P. Kienlin, S. Mommert, A. Kapp, and T. Werfel. 2002. Suppression of IL-12 production by soluble CD40 ligand: evidence for involvement of the p44/42 mitogen-activated protein kinase pathway. J. Immunol. 168:3793-3800.
89. Wolf, K., D. A. Tsakiris, R. Weber, P. Erb, M. Battegay, et al. 2002. Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1. J. Infect. Dis. 185:456-462.
90. Yang, J., Y. Xu, C. Zhu, M. K. Hagan, T. Lawley, and M. K. Offermann. 1994. Regulation of adhesion molecule expression in Kaposi's sarcoma cells. J. Immunol. 152:361-373.
91. + lymphocytes in HIV infection. Clin. Immunol. Immunopathol. 72:328-334.
92. Zietz, C., B. Hotz, M. Sturzl, E. Rauch, R. Penning, and U. Lohrs. 1996. Aortic endothelium in HIV-1 infection: chronic injury, activation, and increased leukocyte adherence. Am. J. Pathol. 149:1887-1898.